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For a long time, biologists focused on accruing data with-
out having a general framework in which to interpret
their results. A suitable analogy would be the way that
one might use observation to discern the details of how
pieces move on a chessboard without knowing the object
of the game. In chess, once the object of the game is
understood, the patterns of movement, and how they ﬁt
together in sequence, suddenly become much clearer. This
appreciation of the reasons behind the patterns brings
with it a level of understanding that is not possible
through detailed examination of each piece’s movement
in isolation.
Analogous understanding is possible in biology. The
great insights of Charles Darwin gave biologists the
‘object of the game’: evolutionary biology provides an
extremely powerful organizational framework in which to
make sense of a bewildering array of observations. Evolu-
tionary principles have allowed biologists to understand
why biological patterns occur in the way that they do,
and scientists now regularly use these principles to
enormous advantage in many contexts.
Despite its power, the principles of evolutionary
biology remain conspicuously absent in much of medical
science. Most modern physicians receive comprehensive
training in several of the life sciences including anatomy,
physiology, immunology, microbiology, biochemistry, and
genetics, but seldom do they receive much training in
evolutionary biology. At ﬁrst glance, this is perhaps
understandable. Given the long list of subjects that must
be mastered by medical students, it might seem impracti-
cal to ask for more. It is quite likely, however, that infus-
ing medical science with principles from evolutionary
biology will have the same positive effect that it has had
in other areas of life science. Not only does evolution
provide a unifying framework from which to understand
the occurrence of disease and illness, but it can also
suggest novel approaches to treatment as well. It therefore
seems reasonable to expect that a modest investment in
evolutionary training by medical scientists could yield
considerable returns. This special issue of Evolutionary
Applications is devoted to advancing this cause.
There are a number of other useful sources of infor-
mation on evolutionary medicine, as well as a variety
of scientiﬁc activities that are planned. The Evolution
and Medicine Review (evmedreview.com) provides news
and commentary on current developments in the ﬁeld,
and the Evolution & Medicine Network (evolutionand-
medicine.org) lists books, meetings, courses, and other
resources for those interested in orienting themselves to
this rapidly emerging ﬁeld. Randy Nesse, who
co-authored the book that founded the ﬁeld, is one of
the guiding lights for both efforts. And shortly after
this issue goes to press, the National Academy of
Sciences (USA) will host a Sackler Symposium on
Evolution in Health and Medicine (http://www.nasonline.
org/site/PageServer?pagename=Sackler_Evolution_Health_
Medicine). Thus, this special issue is one of the many
efforts that recognize the value of evolutionary insights
into medical issues. That evolutionary thought should
now be receiving some recognition as helpful in medi-
cine reﬂects the growing recognition that its insights
can save lives and reduce suffering by suggesting
important alternative explanations, and reducing the
potential for unpleasant surprises.
This special issue
The articles in this special issue are a collection of both
primary research papers and syntheses that illustrate the
utility of taking an evolutionary perspective on topics
relevant to human health and disease. Despite the relative
infancy of evolutionary medicine, researchers have already
applied evolutionary insights to a wide array of medical
issues. Those addressed here include the evolution of
pathogens and infectious diseases, the evolution and
spread of drug resistance in pathogen populations, the
evolutionary biology of cancer, human genetics and
evolution, and the evolutionary biology of immune
responses.
With their long experience in the evolution of host–
parasite interactions, evolutionary biologists contribute
naturally to medicine through the study of infectious
diseases, where they have developed both a wealth of
ideas and some powerful model systems. The ﬁrst paper
by Reece et al. (2009) provides an excellent example: the
authors develop evolutionary explanations for patterns of
pathogenesis in malaria and how they are expected to
respond to environmental factors. They also review some
exciting recent experimental results that test these predic-
tions using a mouse model system. Joseph et al. (2009)
present primary research results from an elegant evolution-
ary model system of bacteria and phage, demonstrating
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tible to further infection. Although these initial results
come from an experimental system quite removed from
human health, they are intriguing because they show that
closely related pathogens can differ markedly in their sus-
ceptibility to co-infection. This is signiﬁcant because theo-
retical considerations show that the extent of co-infection
can greatly affect the evolutionary dynamics of pathogens
and thereby our ability to control disease. The third con-
tribution on infectious diseases, by Brown et al. (2009),
reviews ideas about how bacterial pathogens compete with
one another within a host. Competition can occur via clas-
sical alleleopathy, through phage-mediated killing, and
through differential susceptibility to host defenses. The
authors make an interesting suggestion for how the signiﬁ-
cance of these reactions can be understood within an
evolutionary theory of social interactions.
Another area of medical research in which evolutionary
biology has much to offer is the emergence and spread of
drug resistance in pathogens. This has clearly become an
issue of central concern in modern medicine. Unfortu-
nately, even when medical practitioners recognize the
spread of resistance as an evolutionary problem, they
seldom consider how an understanding of evolutionary
biology might be of further use. But the evolution of drug
resistance goes far beyond the simple observation that
drug resistance evolves. For example, we can use evolu-
tionary knowledge to design drug treatment protocols
that slow the spread of drug resistance and perhaps even
design interventions that use evolutionary change to our
advantage.
Two contributions to this special issue examine the
evolutionary biology of drug resistance in detail. Read
and Huijben (2009) provide a trenchant overview of the
evolution of drug resistance in malaria. They highlight
several fallacies in current thinking on drug use and go
on to describe several very interesting, and still unan-
swered, evolutionary questions. They make the provoca-
tive suggestion that current drug use protocols are
dangerously suboptimal from an evolutionary standpoint.
In a similar vein, Pongtavornpinyo et al. (2009) present
original research on the appearance of drug resistance
mutants in malaria using mathematical models. By
depicting the malaria life cycle in detail, their models
provide compellingly simple expressions for the probabil-
ity of resistant mutants arising in different stages of the
life cycle. One important conclusion is that, in the
presence of drug use, the mutants that are selected for
resistance will most likely arise during the blood stage
portion of the life cycle.
An area of rapidly increasing interest in evolutionary
medicine is the application of evolutionary principles to
the biology of cancer. Evolutionary change by natural
selection occurs whenever there is heritable variation
among individuals in reproductive capacity: precisely the
properties of individual cells within many cancerous
tumours in humans. Thus, it is increasingly thought that
many facets of cancer biology, including incidence,
progression, metastasis, and the emergence of resistance
to treatment, can be better understood by focusing on the
evolution of cell populations within an individual. Pepper
et al. (2009) provide a very nice summary of the state of
play together with intriguing ideas for future research. As
they point out in their article, taking an evolutionary
perspective could yield both ideas for novel and more
lasting treatments, as well as basic insights that emerge
from applying current ideas in evolutionary biology (e.g.,
phylogenetics).
There are many important and devastating illnesses in
humans in addition to infectious diseases and cancer, and
many of these are inﬂuenced by a signiﬁcant genetic
component. Here again an evolutionary perspective is
natural and helpful. The genetic composition of the
current human gene pool, including those genes that are
implicated in human illness, has arisen via descent with
modiﬁcation from that of ancestors. Understanding this
evolutionary process can reveal the origins of genetic
disorders and some of the reasons for their existence.
Modern techniques in molecular biology, including the
sequencing of the human genome (along with that of
other species) have greatly increased our ability to
discover the underlying genetics of such diseases.
Here, Heyer and Quintana-Murci (2009) provide an
excellent overview of how genetic techniques can detect
the effects of natural selection in the human genome.
They illustrate these approaches both for human adapta-
tion to historical environmental conditions and for
understanding the genes underlying some important
human diseases. Crespi et al. (2009) then provide a
comprehensive examination of the genetics underlying
certain neuro-developmental disorders in humans. They
focus on the cognitive and behavioural consequences of
copy number variation in genes, and use association
studies, along with analyses aimed at detecting selection
in the human genome, to understand the causes of such
disorders. The authors make the very interesting sugges-
tion that copy number variation gives rise to phenotypic
variation along an autistic-psychotic spectrum. Varki
et al. (2009) then present an interesting perspective on
the evolutionary biology of heart disease. Instead of look-
ing within humans, the authors exploit the evolutionary
relationship between humans and chimpanzees to better
understand the causes of heart disease in humans.
Surprisingly, although both species suffer from heart
disease, the underlying proximate causes in each appear
to be fundamentally different.
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biology of immune responses. The striking complexity of
the vertebrate immune system has been shaped by
natural selection in response to challenges by pathogens
throughout its evolutionary history. The maintenance
and use of an immune system does not come without
energetic costs; and therefore we expect immune systems
to have evolved different responses to the costs and ben-
eﬁts of defense under different conditions. One of the
chief goals of evolutionary immunology is to understand
and predict how these differences play out.
Sadd and Schmid-Hempel (2009) present a lucid, and
readily accessible, guide to the main principles of evolu-
tionary immunology. They review some of the evidence
for costs of immunity in various study systems, describe
how different factors can give rise to different levels of
investment in components of immunity, and discuss
interesting ways in which pathogens can evolve to evade
or manipulate host immune responses. Fairlie-Clarke
et al. (2009) then probe the cross reactivity of adaptive
immune responses to different antigens. Cross-reactive
immune responses might arise simply through constraints
on antigen recognition, but evolutionary immunology
also suggests that it has evolved as an adaptive strategy.
The authors carefully contrast these possibilities and offer
several promising directions for future research. Finally,
given that the importance of immunity to infection is
likely to vary across life stages, it is to be expected that
this system be physiologically coupled with other aspects
of growth and development. Kopp and Medzhitov (2009)
present stimulating ideas that tie together evolutionary
immunology and the rich evolutionary literature on
senescence and aging. They suggest that infection with
pathogens might select for the ability to alter investment
in growth and reproduction versus somatic maintenance.
The authors review available evidence and suggest how
certain components of the immune system might mediate
these effects.
In closing, we wish to mention that although the
collection of articles presented here provides a compel-
ling case for the utility of evolutionary principles in
medicine, this is really only half the story. Evolutionary
medicine, like all interdisciplinary subjects, is at its best
when information ﬂows in both directions, and medical
studies can yield valuable returns in evolutionary biology
as well. The multi-cohort data-bases available for
humans reﬂect long-term studies in which thousands of
individuals and their offspring have been followed from
birth to death – no other species has been studied in as
much detail. There is also an accumulating set of
impressive cases in which studies undertaken for medical
reasons have shed new light on basic evolutionary issues:
Sebastian Bonhoeffer’s work on the maintenance of
recombination in HIV is one good example. The focus
on only one side of the story in this special issue is pri-
marily a reﬂection of the scope of the journal (i.e., the
application of evolutionary biology to other disciplines).
We encourage interested readers to consult other
sources, including Nesse and Williams (1996), Stearns
and Koella (2008), Trevathan et al. (2008), the Henry
Stewart talks on evolutionary medicine (http://www.
hstalks.com/main/browse_talks.php?father_id=20) and the
talks given at the Yale Symposia on Health and Disease
(http://www.yale.edu/evomedsymposia) for a treatment
of other aspects of evolutionary medicine.
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